The articles included in this review refer to diffuse astrocytomas and anaplastic astrocytomas, independent of their IDH status, as many of the studies included in this review were performed before the wide adoption of the 2016 WHO classification. This evidence concerns the gene IDH2 and anaplastic astrocytoma.